Discover 533 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 533
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Memphis TN, St Louis MO, Jefferson City MO,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT07018323
Phase 2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
for
Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Location: Southhaven MS, Germantown TN, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06545955
Phase 3, Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Southaven MS, Germantown TN, Little Rock AR,
Sponsor: Ferring Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06510374
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
for
Extensive-stage Small-cell Lung Cancer
Location: Southaven MS, Germantown TN, St Louis MO,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712355
Phase 3, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Germantown TN, Little Rock AR, Nashville TN,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
for
Non-Muscle Invasive Bladder Cancer
Location: Germantown TN, Nashville TN, St Louis MO, Knoxville TN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06319820
Phase 3, Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
for
Urinary Bladder Neoplasms,
Location: Germantown TN, Columbia MO, Lafayette LA, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06833073
Phase 2, Recruiting
A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
for
Prostatic Neoplasms
Location: Germantown TN, Lafayette LA, Syracuse NY, Plymouth MA
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT07832292
Phase 2, Recruiting
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
for
Non-Muscle Invasive Bladder Neoplasms
Location: Germantown TN, Atlanta GA, Lafayette LA, Carmel IN,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06919965
Phase 3, Recruiting
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer